-+ 0.00%
-+ 0.00%
-+ 0.00%

CMS expands Medicare coverage for Personalis NeXT Personal test in breast cancer NAT monitoring

PUBT·05/20/2026 20:04:56
Listen to the news
CMS expands Medicare coverage for Personalis NeXT Personal test in breast cancer NAT monitoring
  • Medicare expanded coverage on May 19, 2026, for Personalis’ NeXT Personal test to include monitoring treatment response to neoadjuvant therapy in Stage II-III triple-negative breast cancer or HER2-positive breast cancer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-232533), on May 20, 2026, and is solely responsible for the information contained therein.